Resveratrol synergized the invasion inhibitory effects of 5-FU by inhibiting the EMT transformation of drug-resistant CRC cells via the upregulation of intercellular junctions (desmosomes, claudin-2, and E-cadherin) and downregulation of EMT factors (decreased vimentin and slug) [25]. The gene discussed is VIM; the disease is colorectal carcinoma.